Table 3.
Cessation of benzodiazepine use at 36 months in patients who did and did not stop use at 12 months
| Cessation of BZD at 36 months, n/N (%) | No cessation of BZD at 36 months, n/N (%) | |
|---|---|---|
| Cessation of BZD at 12 months | ||
| SIF group (86/191) | 64/86 (74.4) | 22/86 (25.6) |
| SIW group (76/168) | 49/76 (64.5) | 27/76 (35.5) |
| Control group (26/173) | 18/26 (69.2) | 8/26 (30.8) |
|
| ||
| No cessation of BZD at 12 months | ||
| SIF group (105/191) | 15/105 (14.3) | 90/105 (85.7) |
| SIW group (92/168) | 17/92 (18.5) | 75/92 (81.5) |
| Control group (147/173) | 27/147 (18.4) | 120/147 (81.6) |
Missing values at 12 and 36 months are considered as no cessation. BZD = benzodiazepine. SIF = intervention group with follow-up visits. SIW = intervention group with written instructions.